Trials / Completed
CompletedNCT01443429
A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment
A Pharmacokinetic Study of TRK-100STP -A Single Oral Administration Study in Japanese Patients With Renal Impairment as Compared to Subjects With Normal Renal Function
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Toray Industries, Inc · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The PK and safety profiles to be examined following a single oral administration of TRK-100STP (120 μg) under fasting conditions to patients with renal impairment and to subjects with normal renal function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | beraprost sodium(BPS) |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2011-09-29
- Last updated
- 2014-03-04
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01443429. Inclusion in this directory is not an endorsement.